| scholarly article | Q13442814 |
| P50 | author | Evgeny Vinogradov | Q41459791 |
| P2093 | author name string | Brad Spellberg | |
| Andrew D Cox | |||
| Frank St Michael | |||
| Thomas A Russo | |||
| Ruth Olson | |||
| Anthony A Campagnari | |||
| Janet M Beanan | |||
| Ulrike MacDonald | |||
| Nicole R Luke-Marshall | |||
| P2860 | cites work | Guillain–Barré Syndrome | Q22248108 |
| Serology, chemistry, and genetics of O and K antigens of Escherichia coli | Q24564133 | ||
| Acinetobacter baumannii: an emerging opportunistic pathogen | Q26830893 | ||
| Identification and characterization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesis | Q28274696 | ||
| Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection | Q28478751 | ||
| Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America | Q29616084 | ||
| Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance | Q29617469 | ||
| Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection | Q30419079 | ||
| Molecular mimetics of polysaccharide epitopes as vaccine candidates for prevention of Neisseria meningitidis serogroup B disease | Q30818836 | ||
| Vaccines for preventing typhoid fever. | Q30868028 | ||
| Structural and serological characterisation of the O-antigenic polysaccharide of the lipopolysaccharide from Acinetobacter baumannii strain 24. | Q30886001 | ||
| Identification and characterization of an Acinetobacter baumannii biofilm-associated protein | Q33306299 | ||
| The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation | Q33487075 | ||
| Characterization of a cluster of three glycosyltransferase enzymes essential for Moraxella catarrhalis lipooligosaccharide assembly | Q33755304 | ||
| Antibiotics in the clinical pipeline in 2011. | Q34185670 | ||
| The mimicry of human glycolipids and glycosphingolipids by the lipooligosaccharides of pathogenic neisseria and haemophilus | Q34239641 | ||
| Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies | Q34345623 | ||
| Outbreak of a susceptible strain of Acinetobacter species 13 (sensu Tjernberg and Ursing) in an adult neurosurgical intensive care unit | Q74386940 | ||
| The structures of the carbohydrate backbones of the lipopolysaccharides from Escherichia coli rough mutants F470 (R1 core type) and F576 (R2 core type) | Q77363176 | ||
| Nosocomial infections caused by Acinetobacter baumannii: a major threat worldwide | Q79811610 | ||
| The changing global epidemiology of Acinetobacter baumannii infections: a development with major public health implications | Q79845986 | ||
| Penicillin-binding protein 7/8 contributes to the survival of Acinetobacter baumannii in vitro and in vivo | Q83185555 | ||
| Overview of nosocomial infections caused by gram-negative bacilli | Q34444001 | ||
| Acinetobacter baumannii: emergence of a successful pathogen | Q34795807 | ||
| A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate | Q35878788 | ||
| The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace | Q35905605 | ||
| Atypical infections in tsunami survivors | Q36006736 | ||
| Global challenge of multidrug-resistant Acinetobacter baumannii | Q36095081 | ||
| The epidemiology and control of Acinetobacter baumannii in health care facilities | Q36382140 | ||
| Generation of isogenic K54 capsule-deficient Escherichia coli strains through TnphoA-mediated gene disruption | Q36774334 | ||
| Rat pneumonia and soft-tissue infection models for the study of Acinetobacter baumannii biology | Q36804312 | ||
| Strain-specific and immunodominant surface epitopes of the P2 porin protein of nontypeable Haemophilus influenzae | Q36962031 | ||
| Why are we afraid of Acinetobacter baumannii? | Q37202830 | ||
| How bacterial carbohydrates influence the adaptive immune system | Q37646747 | ||
| Treatment of Acinetobacter infections. | Q37760952 | ||
| Methodology and measurement of the effectiveness of Haemophilus influenzae type b vaccine: systematic review | Q37775203 | ||
| Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy | Q37878485 | ||
| Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y tetanus toxoid conjugate vaccine for infants and toddlers | Q37909415 | ||
| Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe. | Q37910264 | ||
| Polyclonal immunoglobulins and hyperimmune globulins in prevention and management of infectious diseases | Q37952919 | ||
| Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies | Q37956384 | ||
| Passive immunity in the prevention of rabies. | Q38006132 | ||
| Structure and biosynthesis of the capsular antigens of Escherichia coli. | Q38139027 | ||
| Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry | Q38473752 | ||
| Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups | Q38876666 | ||
| Outer membrane protein B1, an iron-repressible protein conserved in the outer membrane of Moraxella (Branhamella) catarrhalis, binds human transferrin | Q39826077 | ||
| The long-distance tertiary air transfer and care of tsunami victims: injury pattern and microbiological and psychological aspects | Q42025143 | ||
| The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor | Q42428390 | ||
| Community-acquired Acinetobacter pneumonia in the Northern Territory of Australia | Q43736106 | ||
| Severe community-acquired pneumonia due to Acinetobacter baumannii. | Q43759955 | ||
| Structural analysis of the lipopolysaccharide of Pasteurella multocida strain VP161: identification of both Kdo-P and Kdo-Kdo species in the lipopolysaccharide. | Q45202810 | ||
| E. coli virulence factor hemolysin induces neutrophil apoptosis and necrosis/lysis in vitro and necrosis/lysis and lung injury in a rat pneumonia model | Q46417447 | ||
| Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis | Q48761076 | ||
| Celebrating the golden anniversary of the discovery of bacillosamine, the diamino sugar of a Bacillus. | Q53179590 | ||
| Capsular polysaccharide and the O-specific antigen impede antibody binding: a potential obstacle for the successful development of an extraintestinal pathogenic Escherichia coli vaccine. | Q54413749 | ||
| Immunologic response of man to group B meningococcal polysaccharide vaccines. | Q54484873 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | polysaccharide | Q134219 |
| immunization | Q1415366 | ||
| Acinetobacter baumannii | Q3241189 | ||
| passive immunization | Q73525231 | ||
| P304 | page(s) | 915-922 | |
| P577 | publication date | 2013-01-07 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization | |
| P478 | volume | 81 |
| Q41989828 | A New Take on an Old Remedy: Generating Antibodies against Multidrug-Resistant Gram-Negative Bacteria in a Postantibiotic World |
| Q40335432 | A medically relevant capsular polysaccharide in Acinetobacter baumannii is a potential vaccine candidate |
| Q37691079 | Antibiotic Resistance Determinant-Focused Acinetobacter baumannii Vaccine Designed Using Reverse Vaccinology |
| Q35101682 | Antibiotic modulation of capsular exopolysaccharide and virulence in Acinetobacter baumannii |
| Q30235064 | Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options |
| Q36964241 | Characterization of a trifunctional glucosyltransferase essential for Moraxella catarrhalis lipooligosaccharide assembly |
| Q59100527 | Characterization of the algC gene expression pattern in the multidrug resistant Acinetobacter baumannii AIIMS 7 and correlation with biofilm development on abiotic surface |
| Q39038590 | Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges |
| Q88346828 | Cloning of ompA gene from Acinetobacter baumannii into the eukaryotic expression vector pBudCE4.1 as DNA vaccine |
| Q86642757 | Considerations for the development of a prophylactic vaccine for Acinetobacter baumannii |
| Q36256352 | Current advances and challenges in the development of Acinetobacter vaccines |
| Q88672734 | Current therapies in treatment and prevention of fracture wound biofilms: why a multifaceted approach is essential for resolving persistent infections |
| Q61449852 | Diversity and Function of Capsular Polysaccharide in |
| Q34157681 | Diversity within the O-linked protein glycosylation systems of acinetobacter species |
| Q38872307 | Five decades of genome evolution in the globally distributed, extensively antibiotic-resistant Acinetobacter baumannii global clone 1. |
| Q91386510 | Human pleural fluid triggers global changes in the transcriptional landscape of Acinetobacter baumannii as an adaptive response to stress |
| Q89965762 | Hybrid Antigens Expressing Surface Loops of ZnuD From Acinetobacter baumannii Is Capable of Inducing Protection Against Infection |
| Q89969471 | Identification of Acinetobacter baumannii loci for capsular polysaccharide (KL) and lipooligosaccharide outer core (OCL) synthesis in genome assemblies using curated reference databases compatible with Kaptive |
| Q35887251 | Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinology |
| Q28539933 | Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models |
| Q36555685 | Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii |
| Q42367786 | Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii |
| Q43819089 | In silico analysis of Acinetobacter baumannii phospholipase D as a subunit vaccine candidate |
| Q33746032 | Induction of human plasmablasts during infection with antibiotic-resistant nosocomial bacteria |
| Q41542663 | Isotype switching: Mouse IgG3 constant region drives increased affinity for polysaccharide antigens |
| Q43563522 | Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis |
| Q40700556 | OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections |
| Q26771783 | Pathogenic Acinetobacter: from the Cell Surface to Infinity and Beyond |
| Q90212156 | Pharmacokinetic and Pharmacodynamic Considerations for the Use of Monoclonal Antibodies in the Treatment of Bacterial Infections |
| Q53701548 | Potential targets for next generation anti-microbial glycoconjugate vaccines. |
| Q40183459 | Small protein A and phospholipase D immunization serves a protective role in a mouse pneumonia model of Acinetobacter baumannii infection. |
| Q35804454 | Structure of the K12 capsule containing 5,7-di-N-acetylacinetaminic acid from Acinetobacter baumannii isolate D36 |
| Q54215291 | Structure of the K2 capsule associated with the KL2 gene cluster of Acinetobacter baumannii. |
| Q47744180 | The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization Strategies |
| Q92404420 | The Mechanisms of Disease Caused by Acinetobacter baumannii |
| Q36956080 | The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumannii |
| Q34685659 | Variation in the complex carbohydrate biosynthesis loci of Acinetobacter baumannii genomes |
Search more.